Vesalius Research Center
Herestraat 49 box 912
B-3000 Leuven

phone +32 16 34 57 75
fax +32 16 34 59 90

O&N
Group Leaders

Peter Carmeliet, Director

Diether Lambrechts
Massimiliano Mazzone
Wim Robberecht
Dietmar Schmucker
Holger Gerhardt

News

Interesting interview with Peter Carmeliet in Circulation: European Perspectives.
“We Are Just Starting to Understand How Vascular Endothelial Growth Factor ‘Shapes’ Vessels and Nerves Into the Vascular and Nervous System and How This Becomes Deranged in Disease”
Read more ...

OXFORD BIOMEDICA and VIB-K.U.LEUVEN announce collaborative research project funded by the Motor Neurone Disease Association to develop MoNuDin® for treatment of Amyotrophic Lateral Sclerosis
Read more ...

Peter Carmeliet awarded the Joseph Maisin Prize for fundamental biomedical sciences for his research on angiogenesis and neurogenesis, which could lead to treatments for cancer, muscular disorders, etc.     Read more ...

Anti-PlGF therapeutic potential further established.     Read more ...

Research on heart and vascular diseases earns Peter Carmeliet the Ernst Jung Medical Award 2010.     Read more ...

Development of Leuven’s candidate medicine against nerve disease ALS moves into higher gear.     Read more ...

Lectures

Methusalem lecture: 5 October 2010, Bruce Spiegelman, PhD, Professor of Cell Biology, Dana Farber Cancer Institute

Jobs

Postdoctoral Fellows, Research Technician (2 positions), Research Scientist     Read more ...

Sponsored by
Methusalem.jpg

VIB     K.U.Leuven